CIK 0001360214
- Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450567010
- Phone
- +1 615-733-4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-14 | BOLL ANDREW R. PRESIDENT AND CFO | Purchase | +3,500 | $29.90 | $105K | 814,679 |
| 2025-12-12 | BOLL ANDREW R. PRESIDENT AND CFO | Exercise or conversion | +60,000 | $3.95 | $237K | 837,844 |
| 2025-12-12 | BOLL ANDREW R. PRESIDENT AND CFO | Shares withheld for taxes | −26,665 | $47.06 | $1.3M | 811,179 |
| 2025-12-12 | BOLL ANDREW R. PRESIDENT AND CFO | Exercise or conversion · Stock Option (Right to Buy) | −60,000 | 0 | ||
| 2025-07-01 | BOLL ANDREW R. CHIEF FINANCIAL OFFICER | Grant or award · RSU | +405,750 | 405,750 | ||
| 2025-04-07 | BOLL ANDREW R. Chief Financial Officer | Shares withheld for taxes | −136,745 | $23.09 | $3.2M | 777,844 |
| 2025-04-03 | BOLL ANDREW R. Chief Financial Officer | Exercise or conversion | +346,500 | 914,589 | ||
| 2025-04-03 | BOLL ANDREW R. Chief Financial Officer | Exercise or conversion · Performance Stock Unit | −346,500 | 0 | ||
| 2024-02-20 | BOLL ANDREW R. CHIEF FINANCIAL OFFICER | Exercise or conversion | +45,000 | $10.67 | $480K | 586,569 |
| 2024-02-20 | BOLL ANDREW R. CHIEF FINANCIAL OFFICER | Exercise or conversion | −18,480 | $10.67 | $197K | 568,089 |
| 2024-02-20 | BOLL ANDREW R. CHIEF FINANCIAL OFFICER | Exercise or conversion · RSU | −45,000 | 0 | ||
| 2024-02-07 | BOLL ANDREW R. CHIEF FINANCIAL OFFICER | Exercise or conversion | +7,400 | $7.71 | $57K | 541,569 |
| 2024-02-07 | BOLL ANDREW R. CHIEF FINANCIAL OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −7,400 | 0 | ||
| 2023-07-18 | BOLL ANDREW R. Chief Financial Officer | Exercise or conversion | +346,500 | 670,519 | ||
| 2023-07-18 | BOLL ANDREW R. Chief Financial Officer | Shares withheld for taxes | −136,350 | $18.23 | $2.5M | 534,169 |
| 2023-07-18 | BOLL ANDREW R. Chief Financial Officer | Exercise or conversion · Performance Stock Unit | −346,500 | 0 | ||
| 2023-04-03 | BOLL ANDREW R. Chief Financial Officer | Grant or award · Restricted Stock Unit | +346,500 | 346,500 | ||
| 2023-03-31 | BOLL ANDREW R. Chief Financial Officer | Exercise or conversion | +90,000 | $6.00 | $540K | 358,461 |
| 2023-03-31 | BOLL ANDREW R. Chief Financial Officer | Shares withheld for taxes | −34,442 | $21.16 | $729K | 324,019 |
| 2023-03-31 | BOLL ANDREW R. Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −90,000 | 0 |
Page 1 of 3 · 56 trades